Efficacy of bazedoxifene for the prevention of postmenopausal osteoporosis: Results of a 2-year, phase III, placebo- and active-controlled study

被引:0
|
作者
Kendler, D. L. [1 ]
Miller, P. D. [2 ]
Christiansen, C. [3 ]
Hoeck, H. C. [3 ]
Adachi, J. D. [4 ]
Lewiecki, E. M. [5 ]
Woodson, G. [6 ]
Ciesielska, M. [7 ]
Chines, A. A. [7 ]
Constantine, G. [7 ]
Delmas, P. D. [8 ,9 ]
机构
[1] Osteoporosis Res Ctr, Vancouver, BC, Canada
[2] Univ Colorado, Med Ctr, Denver, CO 80202 USA
[3] Ctr Clin & Basic Res, Ballerup, Denmark
[4] McMaster Univ, St Josephs Hosp, Hamilton, ON, Canada
[5] New Mexico Clin Res & Osteoporosis Ctr Inc, Albuquerque, NM USA
[6] Atlanta Res Ctr, Decatur, GA USA
[7] Wyeth Pharmaceut, Collegeville, PA USA
[8] Univ Lyon, Lyon, France
[9] INSERM, Res Unit 831, Lyon, France
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1189 / 1189
页数:1
相关论文
共 50 条
  • [41] Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial
    Rovin, Brad H.
    Barratt, Jonathan
    Heerspink, Hiddo J. L.
    Alpers, Charles E.
    Bieler, Stewart
    Chae, Dong-Wan
    Diva, Ulysses A.
    Floege, Juergen
    Gesualdo, Loreto
    Inrig, Jula K.
    Kohan, Donald E.
    Komers, Radko
    Kooienga, Laura Ann
    Lafayette, Richard
    Maes, Bart
    Malecki, Robert
    Mercer, Alex
    Noronha, Irene L.
    Oh, Se Won
    Peh, Chen Au
    Praga, Manuel
    Preciado, Priscila
    Radhakrishnan, Jai
    Rheault, Michelle N.
    Rote, William E.
    Tang, Sydney C. W.
    Tesar, Vladimir
    Trachtman, Howard
    Trimarchi, Hernan
    Tumlin, James A.
    Wong, Muh Geot
    Perkovic, Vlado
    LANCET, 2023, 402 (10417): : 2077 - 2090
  • [42] A Randomized Alendronate-Controlled Trial of Romosozumab: Results of the Phase 3 ARCH Study (Active-contRolled fraCture study in postmenopausal women with osteoporosis at High risk).
    Saag, Kenneth G.
    Petersen, Jeffrey
    Brandi, Maria Luisa
    Karaplis, Andrew
    Lorentzon, Mattias
    Thomas, Thierry
    Maddox, Judy
    Fan, Michelle
    Meisner, Paul
    Grauer, Andreas
    JOURNAL OF BONE AND MINERAL RESEARCH, 2017, 32 : S54 - S55
  • [43] Efficacy, immunogenicity, and safety of an oral influenza vaccine: a placebo-controlled and active-controlled phase 2 human challenge study
    Liebowitz, David
    Gottlieb, Keith
    Kolhatkar, Nikita S.
    Garg, Shaily J.
    Asher, Jason M.
    Nazareno, Jonathan
    Kim, Kenneth
    McIlwain, David R.
    Tucker, Sean N.
    LANCET INFECTIOUS DISEASES, 2020, 20 (04): : 435 - 444
  • [44] Efficacy of iloperidone in the short-term treatment of schizophrenia: a post hoc analysis of pooled patient data from four phase III, placebo- and active-controlled trials
    Citrome, Leslie
    Meng, Xiangyi
    Hochfeld, Marla
    Stahl, Stephen M.
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2012, 27 (01) : 24 - 32
  • [45] Effects of a Novel Aldosterone Synthase Inhibitor for Treatment of Primary Hypertension Results of a Randomized, Double-Blind, Placebo- and Active-Controlled Phase 2 Trial
    Calhoun, David A.
    White, William B.
    Krum, Henry
    Guo, Weinong
    Bermann, Georgina
    Trapani, Angelo
    Lefkowitz, Martin P.
    Menard, Joel
    CIRCULATION, 2011, 124 (18) : 1945 - U124
  • [47] Efficacy and safety of 0.01% atropine for prevention of childhood myopia in a 2-year randomized placebo-controlled study
    Hieda, Osamu
    Hiraoka, Takahiro
    Fujikado, Takashi
    Ishiko, Satoshi
    Hasebe, Satoshi
    Torii, Hidemasa
    Takahashi, Hiroshi
    Nakamura, Yo
    Sotozono, Chie
    Oshika, Tetsuro
    Morimoto, Takeshi
    Nishida, Kohji
    Nishikawa, Noriko
    Song, Young-Seok
    Tokutake, Tomoki
    Nishi, Yasuyo
    Shigeno, Yuta
    Kurihara, Toshihide
    Negishi, Kazuno
    Tsubota, Kazuo
    Ono, Masafumi
    Nakai, Tomoko
    Tan, Donald
    Tanaka, Shiro
    Kinoshita, Shigeru
    JAPANESE JOURNAL OF OPHTHALMOLOGY, 2021, 65 (03) : 315 - 325
  • [48] Efficacy and safety of 0.01% atropine for prevention of childhood myopia in a 2-year randomized placebo-controlled study
    Osamu Hieda
    Takahiro Hiraoka
    Takashi Fujikado
    Satoshi Ishiko
    Satoshi Hasebe
    Hidemasa Torii
    Hiroshi Takahashi
    Yo Nakamura
    Chie Sotozono
    Tetsuro Oshika
    Takeshi Morimoto
    Kohji Nishida
    Noriko Nishikawa
    Young-Seok Song
    Tomoki Tokutake
    Yasuyo Nishi
    Yuta Shigeno
    Toshihide Kurihara
    Kazuno Negishi
    Kazuo Tsubota
    Masafumi Ono
    Tomoko Nakai
    Donald Tan
    Shiro Tanaka
    Shigeru Kinoshita
    Japanese Journal of Ophthalmology, 2021, 65 : 315 - 325
  • [49] Efficacy and Safety of Ustekinumab in Patients with Active Psoriatic Arthritis: 2-year Results From a Phase 3, Multicenter, Double-blind, Placebo-controlled Study
    Kavanaugh, A.
    Puig, L.
    Gottlieb, A. B.
    Ritchlin, C.
    Li, S.
    Wang, Y.
    Mendelsohn, A. M.
    Song, M.
    Rahman, P.
    McInnes, I.
    SWISS MEDICAL WEEKLY, 2014, 144 : 8S - 9S
  • [50] EFFICACY AND SAFETY OF USTEKINUMAB IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS: 2-YEAR RESULTS FROM A PHASE 3, MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY
    Kavanaugh, A.
    Puig, L.
    Gottlieb, A.
    Ritchlin, C.
    Li, S.
    Wang, Y.
    Mendelsohn, A. M.
    Song, M.
    Rahman, P.
    McInnes, I.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 737 - 738